203 related articles for article (PubMed ID: 12225242)
1. Anti-obesity drug development.
Bays H; Dujovne C
Expert Opin Investig Drugs; 2002 Sep; 11(9):1189-204. PubMed ID: 12225242
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of obesity: currently marketed and upcoming agents.
Bays H; Dujovne C
Am J Cardiovasc Drugs; 2002; 2(4):245-53. PubMed ID: 14727970
[TBL] [Abstract][Full Text] [Related]
3. [The pharmacotherapy of obesity].
Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G
Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
5. Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders.
Heal DJ; Gosden J; Smith SL
Br J Clin Pharmacol; 2009 Dec; 68(6):861-74. PubMed ID: 20002080
[TBL] [Abstract][Full Text] [Related]
6. Current and novel approaches to the drug therapy of obesity.
Chaput JP; Tremblay A
Eur J Clin Pharmacol; 2006 Oct; 62(10):793-803. PubMed ID: 16937118
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.
Correia ML; Haynes WG
Expert Opin Emerg Drugs; 2005 Aug; 10(3):643-60. PubMed ID: 16083333
[TBL] [Abstract][Full Text] [Related]
8. Reducing the risk of obesity: defining the role of weight loss drugs.
Ling H; Lenz TL; Burns TL; Hilleman DE
Pharmacotherapy; 2013 Dec; 33(12):1308-21. PubMed ID: 23712541
[TBL] [Abstract][Full Text] [Related]
9. Emerging pharmacological approaches to the treatment of obesity.
Wasan KM; Looije NA
J Pharm Pharm Sci; 2005 Aug; 8(2):259-71. PubMed ID: 16124937
[TBL] [Abstract][Full Text] [Related]
10. Medical management of obesity.
Giri M
Acta Clin Belg; 2006; 61(5):286-94. PubMed ID: 17240746
[TBL] [Abstract][Full Text] [Related]
11. Adipose targets for obesity drug development.
Boss O; Bergenhem N
Expert Opin Ther Targets; 2006 Feb; 10(1):119-34. PubMed ID: 16441232
[TBL] [Abstract][Full Text] [Related]
12. A review of the metabolic effects of controlled-release Phentermine/Topiramate.
Kiortsis DN
Hormones (Athens); 2013; 12(4):507-16. PubMed ID: 24457398
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine for obesity treatment.
Zhang Y; Yu J; Qiang L; Gu Z
Sci China Life Sci; 2018 Apr; 61(4):373-379. PubMed ID: 29623548
[TBL] [Abstract][Full Text] [Related]
14. Drug therapy for obesity.
Dickerson LM; Carek PJ
Am Fam Physician; 2000 Apr; 61(7):2131-8, 2143. PubMed ID: 10779254
[TBL] [Abstract][Full Text] [Related]
15. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
Lau DC; Teoh H
Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
[TBL] [Abstract][Full Text] [Related]
16. Addressing the unmet medical need for safe and effective weight loss therapies.
Arbeeny CM
Obes Res; 2004 Aug; 12(8):1191-6. PubMed ID: 15340099
[TBL] [Abstract][Full Text] [Related]
17. Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk.
Caterson ID; Finer N
Asia Pac J Clin Nutr; 2006; 15 Suppl():55-62. PubMed ID: 16928662
[TBL] [Abstract][Full Text] [Related]
18. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
[TBL] [Abstract][Full Text] [Related]
19. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
Bays H
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy of obesity.
Hofbauer KG; Nicholson JR
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):475-84. PubMed ID: 17115344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]